Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

326.69
-2.6600-0.81%
Volume:30.63K
Turnover:10.03M
Market Cap:43.16B
PE:140.21
High:332.00
Open:329.23
Low:324.48
Close:329.35
52wk High:495.55
52wk Low:205.87
Shares:132.11M
Float Shares:126.15M
Volume Ratio:0.55
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.33
EPS(LYR):2.33
ROE:73.28%
ROA:6.81%
PB:54.69
PE(LYR):140.21

Loading ...

Feb 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 12, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2025

Major Issues Report

Form 8-K - Current report
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Oct 03, 2025

Major Issues Report

Form 8-K - Current report
Oct 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2025

Major Issues Report

Form 8-K - Current report
Sep 10, 2025

Major Issues Report

Form 8-K - Current report
Sep 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities